Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates.
Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium.
For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register.
For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.

Patent details

4126943 Title: MÉTHODES DE TRAITEMENT DE LA DERMATITE ATOPIQUE ET DES TROUBLES ASSOCIÉS

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic information

Application number:
217169697
WO application number:
EP2021057463
Type:
European patent granted for BE
Status:
Open
Publication number:
4126943
WO publication number:
WO2021191220
1rst applicant's nationality:
Translation language:
EPO publication language:
English
SPC number:

Dates

Filing date:
23/03/2021
Grant date:
22/04/2026
EP publication date:
08/02/2023
WO publication date:
30/09/2021
Claims translation received date:
Translation received date (EP publication B1):
Translation received date (EP publication B2):
Translation received date (EP publication B3):
Registration date:
22/04/2026
EP B1 publication date:
22/04/2026
EP B2 publication date:
EP B3 publication date:
Lapsed date:
Expiration date (if granted and all annual fees paid):
23/03/2041

Applicant

Name:
MedImmune Limited
Legal Form:
From:
22/04/2026
Address:
1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge CB2 0AA, United Kingdom (GB)
To:

Inventor

1

Name:
COLICE, Gene
Legal Form:
Address:
Gaithersburg, Maryland 20878, United States (US)

2

Name:
VAN DER MERWE, Rene
Legal Form:
Address:
Cambridgeshire SG8 7RE, United Kingdom (GB)

3

Name:
BAVEREL, Paul
Legal Form:
Address:
Cambridge Cambridgeshire CB2 8RA, United Kingdom (GB)

Priority

1

Priority patent number:
2020260519
Priority date:
30/10/2020
Priority country:
Australia (AU)

2

Priority patent number:
3097453
Priority date:
30/10/2020
Priority country:
Canada (CA)

3

Priority patent number:
2020182046
Priority date:
30/10/2020
Priority country:
Japan (JP)

4

Priority patent number:
202017084957
Priority date:
30/10/2020
Priority country:
United States (US)

5

Priority patent number:
202063068593 P
Priority date:
21/08/2020
Priority country:
United States (US)

6

Priority patent number:
202063061497 P
Priority date:
05/08/2020
Priority country:
United States (US)

7

Priority patent number:
202063037783 P
Priority date:
11/06/2020
Priority country:
United States (US)

8

Priority patent number:
202062993443 P
Priority date:
23/03/2020
Priority country:
United States (US)

Classification

IPC or IDT classification:
C07K 16/24; A61K 31/573; A61K 39/395; A61P 17/00; A61P 31/04;

Publication

European Patent Bulletin

Issue number:
202617
Publication date:
22/04/2026
Description:
Grant (B1)

Annual fee

Annual fee(s) Due Date:
31/03/2027
Annual fee number:
7
Annual fee amount:
110 Euro
Expected payer:
Last annual fee payment date:
Last annual fee paid number:
Payer:
Filing date Document type Publication Type Document Description Number of pages File Type